Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells
Julia Sung, Joy Pickeral, Liqin Liu, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 11, pp. 4077-4090
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 8, pp. 585-608
Closed Access | Times Cited: 1002
The making of bispecific antibodies
Ulrich Brinkmann, Roland E. Kontermann
mAbs (2017) Vol. 9, Iss. 2, pp. 182-212
Open Access | Times Cited: 781
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks, Sharon R. Lewin, Anna Laura Ross, et al.
Nature Medicine (2016) Vol. 22, Iss. 8, pp. 839-850
Open Access | Times Cited: 404
Targeting the Latent Reservoir for HIV-1
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 316
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
Neha N. Parayath, Sirkka B. Stephan, Amanda Koehne, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 291
Latency reversal and viral clearance to cure HIV-1
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 222
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Nancie M. Archin, Jennifer Kirchherr, Julia Sung, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 8, pp. 3126-3135
Open Access | Times Cited: 177
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis, Nancie M. Archin, Myron S. Cohen, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 189-206
Open Access | Times Cited: 155
Bispecific antibodies targeting mutantRASneoantigens
Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J. Mog, et al.
Science Immunology (2021) Vol. 6, Iss. 57
Open Access | Times Cited: 135
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells
Nathan L. Board, Yuan Zhe, Fengting Wu, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 462-470
Open Access | Times Cited: 22
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
Constantinos Petrovas, Sara Ferrando‐Martínez, Michael Y. Gerner, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 373
Open Access | Times Cited: 148
Use of broadly neutralizing antibodies for HIV‐1 prevention
Amarendra Pegu, Ann J. Hessell, John R. Mascola, et al.
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 296-312
Open Access | Times Cited: 146
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency
Stylianos Bournazos, Anna Gazumyan, Michael S. Seaman, et al.
Cell (2016) Vol. 165, Iss. 7, pp. 1609-1620
Open Access | Times Cited: 136
T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics
Zhanhong Wu, Nai‐Kong V. Cheung
Pharmacology & Therapeutics (2017) Vol. 182, pp. 161-175
Open Access | Times Cited: 125
Why and where an HIV cure is needed and how it might be achieved
Thumbi Ndung’u, Joseph M. McCune, Steven G. Deeks
Nature (2019) Vol. 576, Iss. 7787, pp. 397-405
Open Access | Times Cited: 124
Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases
Krupa Naran, Trishana Nundalall, Shivan Chetty, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 104
Antibody-dependent cellular cytotoxicity in HIV infection
Donald N. Forthal, Andrés Finzi
AIDS (2018) Vol. 32, Iss. 17, pp. 2439-2451
Open Access | Times Cited: 89
Engaging innate immunity in HIV-1 cure strategies
Nathan L. Board, Milica Moskovljevic, Fengting Wu, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 8, pp. 499-512
Open Access | Times Cited: 74
In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Paula M. Cevaal, Ali Abdalla, Ewa Czuba‐Wojnilowicz, et al.
ACS Nano (2021) Vol. 15, Iss. 3, pp. 3736-3753
Open Access | Times Cited: 71
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases
Camille Rolin, Jacques Zimmer, Carole Seguin‐Devaux
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 7, pp. 643-661
Open Access | Times Cited: 14
Reversal of Latency as Part of a Cure for HIV-1
Thomas A. Rasmussen, Martin Tolstrup, Ole S. Søgaard
Trends in Microbiology (2015) Vol. 24, Iss. 2, pp. 90-97
Closed Access | Times Cited: 91
A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies
Shilei Ding, Maxime Veillette, Mathieu Coutu, et al.
Journal of Virology (2015) Vol. 90, Iss. 4, pp. 2127-2134
Open Access | Times Cited: 78
Humanized Mouse Models for Human Immunodeficiency Virus Infection
Matthew D. Marsden, Jerome A. Zack
Annual Review of Virology (2017) Vol. 4, Iss. 1, pp. 393-412
Open Access | Times Cited: 73
Impact of HIV-1 Envelope Conformation on ADCC Responses
Jonathan Richard, Jérémie Prévost, Nirmin Alsahafi, et al.
Trends in Microbiology (2017) Vol. 26, Iss. 4, pp. 253-265
Closed Access | Times Cited: 72
Broadly neutralizing antibodies for the treatment and prevention of HIV infection
Marina Caskey
Current Opinion in HIV and AIDS (2019) Vol. 15, Iss. 1, pp. 49-55
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top